Telix Pharmaceuticals Limited (TLPPF)
USD 15.71
(0.0%)
USD 15.71
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 502.54 Million | 155.98 Million | 4.89 Million | 4.68 Million | 3.48 Million | 195.14 Thousand |
| Cost of Revenue | 188.15 Million | 61.55 Million | 2.54 Million | 2.02 Million | 2.54 Million | - |
| Gross Profit | 314.39 Million | 94.42 Million | 2.35 Million | 2.65 Million | 942 Thousand | 195.14 Thousand |
| Operating Expenses | 298.55 Million | 189.44 Million | 101.15 Million | 52.44 Million | 41.19 Million | 27.84 Million |
| Selling, General and Administrative Expenses | 133.85 Million | 93.5 Million | 40.81 Million | 19.2 Million | 11.58 Million | 9.07 Million |
| Research and Development Expenses | 128.84 Million | 57.85 Million | 34.13 Million | 23.08 Million | 21.16 Million | 18.69 Million |
| Other Expenses | 35.85 Million | 3.08 Million | 23.55 Million | 2.95 Million | 11.44 Million | 11.62 Million |
| Cost and Expenses | 486.7 Million | 251 Million | 103.69 Million | 54.46 Million | 43.74 Million | 27.84 Million |
| Operating Income | 15.84 Million | -92.2 Million | -75.24 Million | -46.76 Million | -28.71 Million | -15.68 Million |
| Interest Expense | 13.13 Million | 6.41 Million | 5.21 Million | 1.17 Million | 2.4 Million | 29.01 Thousand |
| Income Tax Expense | -2.12 Million | 5.45 Million | 45 Thousand | -3.04 Million | -3.25 Million | -1.88 Million |
| Earnings before Tax | 3.08 Million | -98.62 Million | -80.46 Million | -47.93 Million | -31.12 Million | -15.71 Million |
| Net Income | 5.21 Million | -104.07 Million | -80.51 Million | -44.88 Million | -27.86 Million | -13.82 Million |
| Earnings Per Share Basic | 0.02 | -0.34 | -0.29 | -0.17 | -0.12 | -0.07 |
| Earnings Per Share Diluted | 0.02 | -0.34 | -0.29 | -0.17 | -0.12 | -0.07 |
| Weighted Average Shares Outstanding | 323.66 Million | 310.64 Million | 282.2 Million | 257.27 Million | 233.43 Million | 202.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 323.71 Million | 310.64 Million | 282.2 Million | 257.27 Million | 233.43 Million | 202.12 Million |
| Gross Margin | 0.63 | 0.61 | 0.48 | 0.57 | 0.27 | 1.00 |
| EBIT Margin | 0.05 | -0.56 | -14.31 | -8.95 | -7.02 | -80.34 |
| Profit Margin | 0.01 | -0.67 | -16.44 | -9.59 | -8.00 | -70.87 |
| EBITDA | 22.96 Million | -86.82 Million | -70.07 Million | -41.87 Million | -24.47 Million | -15.67 Million |
| Earnings Before Tax Margin | 0.03 | -0.59 | -15.36 | -9.99 | -8.24 | -80.38 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 188.96 Million | 175 Million | 502.54 Million | 281.71 Million | 140.85 Million | 220.83 Million |
| Cost of Revenue | 78.62 Million | 59.47 Million | 187.76 Million | 57.73 Million | 54.18 Million | 130.02 Million |
| Gross Profit | 110.33 Million | 115.52 Million | 314.78 Million | 223.97 Million | 86.66 Million | 90.81 Million |
| Operating Expenses | 96.85 Million | 84.51 Million | 263.27 Million | 203.9 Million | 79.04 Million | 59.37 Million |
| Selling, General and Administrative Expenses | 49.35 Million | 46.1 Million | - | 105.5 Million | 28.98 Million | 28.92 Million |
| Research and Development Expenses | 45.78 Million | 38.4 Million | - | 98.39 Million | 49.19 Million | 30.44 Million |
| Other Expenses | 1.72 Million | - | -29.33 Million | - | - | - |
| Cost and Expenses | 175.48 Million | 143.99 Million | 451.03 Million | 261.63 Million | 133.23 Million | 189.39 Million |
| Operating Income | 13.47 Million | 31 Million | 51.51 Million | 20.07 Million | 10.17 Million | 31.43 Million |
| Interest Expense | 4.94 Million | 3.73 Million | 990 Thousand | 548 Thousand | - | 442 Thousand |
| Income Tax Expense | 2.53 Million | 7.56 Million | -2.12 Million | -4.14 Million | 2.07 Million | 2.02 Million |
| Earnings before Tax | 9.14 Million | 25.53 Million | 3.08 Million | 15.38 Million | 7.69 Million | -12.3 Million |
| Net Income | 11.68 Million | 17.97 Million | 5.21 Million | 19.53 Million | 9.76 Million | -14.32 Million |
| Earnings Per Share Basic | 0.04 | 0.06 | - | 0.06 | 0.03 | -0.05 |
| Earnings Per Share Diluted | 0.03 | 0.05 | - | 0.06 | 0.03 | -0.05 |
| Weighted Average Shares Outstanding | 346.18 Million | 323.85 Million | 319.18 Million | 323.72 Million | 329.71 Million | 317.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 346.18 Million | 331.62 Million | 323.71 Million | 323.72 Million | 329.79 Million | 317.62 Million |
| Gross Margin | 0.58 | 0.66 | 0.63 | 0.80 | 0.62 | 0.41 |
| EBIT Margin | 0.11 | 0.18 | - | 0.08 | 0.08 | 0.16 |
| Profit Margin | 0.06 | 0.10 | 0.01 | 0.07 | 0.07 | -0.06 |
| EBITDA | 20.36 Million | 32.34 Million | - | 23.71 Million | 11.54 Million | 34.72 Million |
| Earnings Before Tax Margin | 0.07 | 0.18 | 0.10 | 0.07 | 0.07 | 0.14 |
TAPG
2160
HRME
ASHNI
STT-PG
SMBC